Dendritic cell-derived exosomes: A new horizon in personalized cancer immunotherapy?
Authors:
- 7 April 2023
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 562, 216168
Abstract
No abstract availableKeywords
Funding Information
- Tabriz University of Medical Sciences (70491)
This publication has 113 references indexed in Scilit:
- Cancer immunotherapy via dendritic cellsNature Reviews Cancer, 2012
- Cross-dressed dendritic cells drive memory CD8+ T-cell activation after viral infectionNature, 2011
- Membrane vesicles as conveyors of immune responsesNature Reviews Immunology, 2009
- Therapeutic effect of exosomes from indoleamine 2,3‐dioxygenase–positive dendritic cells in collagen‐induced arthritis and delayed‐type hypersensitivity disease modelsArthritis & Rheumatism, 2009
- Dendritic cells and cytokines in human inflammatory and autoimmune diseasesCytokine & Growth Factor Reviews, 2008
- Different types of in vitro generated human monocyte‐derived dendritic cells release exosomes with distinct phenotypesImmunology, 2008
- T cell‐induced secretion of MHC class II–peptide complexes on B cell exosomesThe EMBO Journal, 2007
- Mature dendritic cells pulsed with exosomes stimulate efficient cytotoxic T‐lymphocyte responses and antitumour immunityImmunology, 2007
- Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patientsCancer Immunology, Immunotherapy, 2006
- Exosomes: endosomal-derived vesicles shipping extracellular messagesCurrent Opinion in Cell Biology, 2004